Bortezomib-based Anthracycline-free Induction for Pediatric Relapsed ALL as a Bridge to Immunotherapy. Dadi G, Jacoby E, Toren A, Bielorai B, et al. J Pediatr Hematol Oncol 2022;44:e896-e900.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dadi G, Jacoby E, Toren A, Bielorai B, et al. Bortezomib-based Anthracycline-free Induction for Pediatric Relapsed ALL as a Bridge to Immunotherapy. J Pediatr Hematol Oncol 2022;44:e896-e900.
PMID: 34486548